[Benzodiazepine-related disorders].
Sugiyama
Takeshi
T
Saitama Prefectural Psychiatric Hospital.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects*; D015928:Cognitive Behavioral Therapy; D006801:Humans; D011433:Propranolol / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000209:etiology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy
D000319:Adrenergic beta-Antagonists; D000929:Antidepressive Agents, Tricyclic; D001569:Benzodiazepines; D011433:Propranolol; D017367:Selective Serotonin Reuptake Inhibitors